Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis.

European journal of human genetics : EJHG - 1 Jul 2009

Need Anna C, Keefe Richard S E, Ge Dongliang, Grossman Iris, Dickson Sam, McEvoy Joseph P, Goldstein David B

Abstract excerpt

The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Phase 1 Schizophrenia trial compared the effectiveness of one typical and four atypical antipsychotic medications. Although trials such as CATIE present important opportunities for pharmacogenetics research, the very richness of the clinical data presents challenges for statistical interpretation, and in particular the risk that data mining...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cognition

Share to GTP-Binding Proteins

Share to Patient Compliance

Share to Schizophrenic Psychology

Share to Statistics as Topic

Share to Weight Gain

Source

Open in PubMed Open full text

Identifiers

PMID: 19156168
DOI: 10.1038/ejhg.2008.264
PMCID: PMC2986499

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis.PMID 19156168Read ↗

Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study.Semantic proximity Read ↗

Toward understanding genetic risk for differential antipsychotic response in individuals with schizophreniaSemantic proximity Read ↗

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.Semantic proximity Read ↗

A candidate gene study of tardive dyskinesia in the CATIE schizophrenia trialSemantic proximity Read ↗

Genotypic variation in the SV2C gene impacts response to atypical antipsychotics the CATIE study.Semantic proximity Read ↗

Genome-wide association study on antipsychotic-induced weight gain in the CATIE sample.Semantic proximity Read ↗

Pharmacogenetics and outcome with antipsychotic drugsSemantic proximity Read ↗

The pharmacogenetics of antipsychotic treatment.Semantic proximity Read ↗

Pharmacogenomics can improve antipsychotic treatment in schizophreniaSemantic proximity Read ↗

Pharmacogenetics of antipsychotics: Clinical utility and implementationSemantic proximity Read ↗

Pharmacogenetics of Response to Antipsychotics in Patients with SchizophreniaSemantic proximity Read ↗

Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.